Medicine and Dentistry
Liver Cirrhosis
100%
Cohort Analysis
67%
Ascites
33%
Hepatocellular Carcinoma
21%
Alcohol-Related Liver Disease
21%
Hepatic Encephalopathy
16%
Comorbidity
15%
Alcohol Liver Cirrhosis
15%
Prevalence
15%
Hazard Ratio
15%
Liver Cancer
10%
Primary Biliary Cirrhosis
10%
Alcohol Liver Disease
9%
Proton-Pump Inhibitor
9%
Cholangiocarcinoma
9%
Hepatitis C
9%
Autoimmune Hepatitis
8%
Nonalcoholic Fatty Liver
7%
Alcoholic Polyneuropathy
7%
Proportional Hazards Model
7%
Mortality Rate
7%
Hepatitis C Virus
6%
Case-Control Study
6%
Odds Ratio
6%
Alcohol Consumption
6%
Diabetes
6%
Myocardial Infarction
5%
Specific Mortality
5%
Outpatient
5%
Keyphrases
Cirrhosis
59%
National Cohort Study
33%
Alcoholic Cirrhosis
30%
Denmark
30%
Ascites
28%
Alcoholic Liver Disease
23%
Hepatocellular Carcinoma
18%
Confidence Interval
18%
Autoimmune Hepatitis
16%
Risk Factors
14%
Hepatic Encephalopathy
11%
Registry-based
10%
Comorbidity
9%
Nationwide Registers
9%
Incidence Rate
9%
Proton Pump Inhibitors
9%
Nationwide Registry
8%
Population-based Cohort Study
8%
Liver Cirrhosis
8%
Population-based Study
7%
Danish Population
7%
Clinical Course
7%
Hepatitis C Virus Infection
7%
Socioeconomic Status
6%
Register Study
6%
Hazard Ratio
6%
1-year Mortality
6%
Cirrhotic Ascites
6%
Time Trends
6%
Resection
6%
Health Registries
5%
Liver
5%
Variceal Bleeding
5%
Adjusted Hazard Ratio
5%
Hepatitis C Virus
5%
Hepatocellular Carcinoma Surveillance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
71%
Cohort Study
49%
Ascites
34%
Prevalence
23%
Alcohol Liver Cirrhosis
15%
Comorbidity
15%
Autoimmune Hepatitis
11%
Hepatitis C
10%
Liver Cell Carcinoma
10%
Hepatic Encephalopathy
9%
Primary Biliary Cirrhosis
9%
Hepatitis C Virus
8%
Proton Pump Inhibitor
7%
Alcohol Liver Disease
7%
Case-Control Study
6%
Toxic Injury
6%
Liver Cancer
5%
Disease Course
5%
Statin (Protein)
5%
